The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with metastatic solid cancers treated on early phase clinical trials in western Australia.
 
Ahmad Sufian Ab Rahman
Employment - Linear Clinical Research Ltd
 
Mohammad Usman Hakeem
No Relationships to Disclose
 
Randa Abass
No Relationships to Disclose
 
Laura Wainman
Employment - Linear Clinical Research Ltd
 
Jake Miller
Employment - Linear Clinical Research Ltd
 
Afaf Abed
No Relationships to Disclose
 
Timothy Guy Humphries
No Relationships to Disclose
 
Tarek Meniawy
Consulting or Advisory Role - BMS; Eisai; Eisai; GlaxoSmithKline; MSD; MSD; Novartis; Regeneron; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck Serono (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS; Eisai
 
Rajiv Shinde
Travel, Accommodations, Expenses - Bayer
 
Peter Kar Han Lau
Employment - George Clincal
Honoraria - Bristol-Myers Squibb; Lilly; MSD
Consulting or Advisory Role - Immunocore; MSD
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Beigene (Inst); Bristol Myers Squibb (Inst); Gilead Sciences (Inst); Iksuda (Inst); Immunocore (Inst); Lilly (Inst); MSD (Inst); Olema Oncology (Inst); Pfizer (Inst); Pimera (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche/Genentech
 
Samantha Bowyer
Honoraria - Bristol-Myers Squibb/Medarex; MSD; Sanofi
Consulting or Advisory Role - Ipsen; MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology
 
Michael Millward
Consulting or Advisory Role - AstraZeneca; BeiGene; IQvia; Lilly; The Limbic
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Albion Laboratories (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); Apollomics (Inst); AstraZeneca (Inst); AtriCure (Inst); Axelia Oncology (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); Cullinan Oncology (Inst); Dizal Pharma (Inst); Eucure Biopharma (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genfleet Therapeutics (Inst); GlaxoSmithKline (Inst); IMPAC Medical Systems (Inst); InventisBio (Inst); InxMed (Inst); Kinnate Biopharma (Inst); Lilly (Inst); Maxinovel (Inst); Relay Therapeutics (Inst); Turning Point Therapeutics (Inst); Tyra Biosciences (Inst); Vivace Therapeutics (Inst)